Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Adults
Older adults
2020
Clear all
Type of publications
NITAG documentation
(2)
Systematic reviews (SYSVAC)
(77)
Topics
Available to download in languages
Regions
Americas
(4)
Europe
(1)
Western Pacific
(6)
Countries
Diseases
COVID-19
(61)
Human papillomavirus (HPV)
(18)
Diphtheria
(1)
Ebola
(1)
Haemophilus influenzae type B
(1)
Hepatitis B
(1)
Influenza
(6)
Pertussis
(1)
Pneumococcal disease
(3)
Tetanus
(1)
Tick-borne encephalitis
(1)
Tuberculosis
(2)
Vaccine topics
Acceptance
(3)
Administration
(3)
Coverage
(5)
Economic aspects
(3)
Efficacy/effectiveness
(11)
Ethical issues
(2)
Modeling
(1)
Safety
(6)
Target population
Adults
(76)
Older adults
(59)
Adolescents
(26)
All age groups
(68)
Children
(5)
Healthcare workers
(13)
Newborn
(2)
Parents/caregivers
(6)
Pregnant women
(7)
Risk group
(3)
Travellers
(1)
Publication date
2020
(79)
2024
(1)
2023
(83)
2022
(270)
2021
(140)
2019
(12)
2018
(12)
2017
(13)
2016
(17)
2015
(13)
2014
(15)
2013
(4)
2012
(7)
2011
(1)
79 results found
2020
∙
Biswas, M. Rahaman, S. Biswas, T. K. Haque, Z. Ibrahim, B. oa
Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis
2020
∙
Zhang, J. Wu, J. Sun, X. Xue, H. Shao, J. Cai, W. Jing, Y. Yue, M. Dong, C.
Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis
2020
∙
Jorgensen, L. Gotzsche, P. C. Jefferson, T.
Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publications
2020
∙
Jorgensen, L. Gotzsche, P. C. Jefferson, T.
Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports
2020
∙
Pranata, Raymond Lim, Michael Anthonius Yonas, Emir Vania, Rachel Lukito, Antonia Anna Siswanto, Bambang Budi Meyer, Markus
Body Mass Index and Outcome in Patients with COVID-19: A Dose-Response Meta-Analysis
2020
∙
Liu, H. Chen, S. Liu, M. Nie, H. Lu, H.
Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis
2020
∙
Guo, Li Shi, Zumin Zhang, Ya Wang, Cuicui Cristina Do Vale Moreira, Nayla Zuo, Hui Hussain, Akhtar
Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: a meta-analysis
2020
∙
Zhou, Yue Yang, Qing Chi, Jingwei Dong, Bingzi Lv, Wenshan Shen, Liyan Wang, Yangang
Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis
2020
∙
Mahumud, R. A. Alam, K. Keramat, S. A. Ormsby, G. M. Dunn, J. Gow, J.
Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
2020
∙
Rocha, A. P. D. Atallah Á, N. Pinto, Acpn Rocha-Filho, C. R. Milby, K. M. Civile, V. T. Carvas Junior, N. Reis, F. S. A. Ferla, L. J. Ramalho, G. S. Trevisani, G. F. M. Puga, Meds Trevisani, V. F. M.
COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register